XML 17 R4.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
¥ in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2021
CNY (¥)
¥ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2020
CNY (¥)
¥ / shares
shares
Dec. 31, 2019
CNY (¥)
¥ / shares
shares
Revenues, net of value-added tax ¥ 485,633 $ 76,206 ¥ 223,011 ¥ 198,363
Cost of revenues (542,530) (85,135) (209,928) (214,193)
Gross profit (loss) (56,897) (8,929) 13,083 (15,830)
Operating expenses:        
Selling expenses (53,675) (8,423) (25,761) (30,241)
General and administrative expenses (347,746) (54,569) (294,823) (315,134)
Impairment of long-lived assets 0 0 (8,500) (76,089)
Operating loss (458,318) (71,921) (316,001) (437,294)
Interest expense (including interest expense to related party amounting to RMB151, RMB41,918 and RMB13,532 (US$2,124) for the years ended December 31, 2019, 2020 and 2021, respectively) (73,789) (11,579) (81,359) (28,700)
Foreign exchange gain (loss) , net (19,925) (3,127) (58,686) 34,990
Gain (loss) on disposal of long-lived assets 0 0 677 (1,299)
Interest income (including interest income from related party amounting to RMB206, RMB127 and RMB3,447(US$541) for the years ended December 31, 2019, 2020 and 2021, respectively) 5,894 925 8,440 9,165
Change in fair value of derivative liability (39) (6)   0
Income (loss) from equity method investments 18,163 2,850 6,021 (5,078)
Loss on disposal of subsidiaries 0 0 (14,894) 0
Other (expenses) income, net (1,223) (192) 6,312 37,138
Gain on disposal of an equity method investment 0 0 7,837 0
Loss before income tax (529,237) (83,050) (441,653) (391,078)
Income tax (expenses) benefit 6,565 1,030 37,624 38,986
Net loss (522,672) (82,020) (404,029) (352,092)
Net loss attributable to noncontrolling interests 251,245 39,426 94,040 45,043
Net loss attributable to Concord Medical Services Holdings Limited ¥ (271,427) $ (42,594) ¥ (309,989) ¥ (307,049)
Loss per share for Class A and Class B ordinary shares:        
Basic and diluted | (per share) ¥ (6.26) $ (0.98) ¥ (5.11) ¥ (4.24)
Weighted average number of class A and class B ordinary shares outstanding:        
Basic and diluted 131,053,858 131,053,858 131,053,858 130,238,498
Other comprehensive income (loss), net of tax of nil        
Foreign currency translation, net tax of nil ¥ 14,821 $ 2,326 ¥ 50,856 ¥ (8,664)
Total other comprehensive income (loss), net of tax 14,821 2,326 50,856 (8,664)
Comprehensive loss (507,851) (79,694) (353,173) (360,756)
Comprehensive loss attributable to noncontrolling interests (251,245) (39,426) (94,040) (43,930)
Comprehensive loss attributable to Concord Medical Services Holdings Limited (256,606) (40,268) (259,133) (316,826)
Equipment Leasing Revenues        
Revenues, net of value-added tax 42,484 6,667 52,906 58,559
Cost of revenues (40,539) (6,361) (36,911) (77,730)
Services and other revenues        
Revenues, net of value-added tax 383,828 60,230 140,050 117,027
Cost of revenues (441,510) (69,283) (143,443) (119,096)
Medicine income        
Revenues, net of value-added tax 59,321 9,309 30,055 22,777
Cost of revenues ¥ (60,481) $ (9,491) ¥ (29,574) ¥ (17,367)